We will expand surveillance to include surveillance for SARS-CoV-2 and RSV in outpatient settings to monitor treatment use and effectiveness, potentially inform vaccine impact, and understand the full spectrum of SARS-CoV-2 and RSV.
COVID-19 and RSV Non-Hospitalized Surveillance
Investigator: Skarbinski, Jacek
Funder: Centers for Disease Control and Prevention
